• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响下肢主干静脉功能不全患者行腔内激光消融术时最佳线性静脉内能量密度的因素——临床证据综述

Factors affecting optimal linear endovenous energy density for endovenous laser ablation in incompetent lower limb truncal veins - A review of the clinical evidence.

作者信息

Cowpland Christine A, Cleese Amy L, Whiteley Mark S

机构信息

1 The Whiteley Clinic, Stirling House, UK.

2 Faculty of Health and Biomedical Sciences, University of Surrey, UK.

出版信息

Phlebology. 2017 Jun;32(5):299-306. doi: 10.1177/0268355516648067. Epub 2016 May 12.

DOI:10.1177/0268355516648067
PMID:27178405
Abstract

Objectives The objective is to identify the factors that affect the optimal linear endovenous energy density (LEED) to ablate incompetent truncal veins. Methods We performed a literature review of clinical studies, which reported truncal vein ablation rates and LEED. A PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) flow diagram documents the search strategy. We analysed 13 clinical papers which fulfilled the criteria to be able to compare results of great saphenous vein occlusion as defined by venous duplex ultrasound, with the LEED used in the treatment. Results Evidence suggests that the optimal LEED for endovenous laser ablation of the great saphenous vein is >80 J/cm and <100 J/cm in terms of optimal closure rates with minimal side-effects and complications. Longer wavelengths targeting water might have a lower optimal LEED. A LEED <60 J/cm has reduced efficacy regardless of wavelength. The optimal LEED may vary with vein diameter and may be reduced by using specially shaped fibre tips. Laser delivery technique and type as well as the duration time of energy delivery appear to play a role in determining LEED. Conclusion The optimal LEED to ablate an incompetent great saphenous vein appears to be >80 J/cm and <95 J/cm based on current evidence for shorter wavelength lasers. There is evidence that longer wavelength lasers may be effective at LEEDs of <85 J/cm.

摘要

目的 目的是确定影响消融功能不全的主干静脉的最佳线性静脉内能量密度(LEED)的因素。方法 我们对报告主干静脉消融率和LEED的临床研究进行了文献综述。一份PRISMA(系统评价和Meta分析的首选报告项目)流程图记录了检索策略。我们分析了13篇符合标准的临床论文,以便能够将静脉双重超声定义的大隐静脉闭塞结果与治疗中使用的LEED进行比较。结果 证据表明,就具有最小副作用和并发症的最佳闭合率而言,大隐静脉腔内激光消融的最佳LEED为>80 J/cm且<100 J/cm。针对水的较长波长可能具有较低的最佳LEED。无论波长如何,LEED<60 J/cm会降低疗效。最佳LEED可能随静脉直径而变化,并且使用特殊形状的光纤尖端可能会降低最佳LEED。激光输送技术和类型以及能量输送的持续时间似乎在确定LEED中起作用。结论 根据目前关于较短波长激光的证据,消融功能不全的大隐静脉的最佳LEED似乎为>80 J/cm且<95 J/cm。有证据表明,较长波长的激光在<85 J/cm的LEED下可能有效。

相似文献

1
Factors affecting optimal linear endovenous energy density for endovenous laser ablation in incompetent lower limb truncal veins - A review of the clinical evidence.影响下肢主干静脉功能不全患者行腔内激光消融术时最佳线性静脉内能量密度的因素——临床证据综述
Phlebology. 2017 Jun;32(5):299-306. doi: 10.1177/0268355516648067. Epub 2016 May 12.
2
The relative roles of power, linear endovenous energy density, and pullback velocity in determining short-term success after endovenous laser ablation of the truncal saphenous veins.在静脉内激光消融治疗主干大隐静脉后,功率、线性静脉内能量密度和回撤速度在确定短期疗效方面的相对作用。
J Vasc Surg Venous Lymphat Disord. 2019 Jan;7(1):90-97. doi: 10.1016/j.jvsv.2018.07.018. Epub 2018 Nov 15.
3
A randomized clinical trial to assess the impact of laser power with constant linear endovenous energy density on outcomes of endovenous laser ablation (SLEDGE trial).一项评估恒定线性静脉内能量密度的激光功率对静脉内激光消融结局影响的随机临床试验(SLEDGE 试验)。
J Vasc Surg Venous Lymphat Disord. 2023 Sep;11(5):946-953. doi: 10.1016/j.jvsv.2023.03.020. Epub 2023 May 11.
4
A description of the 'smile sign' and multi-pass technique for endovenous laser ablation of large diameter great saphenous veins.大隐静脉内径较大时行静脉腔内激光消融的“微笑征”及多通道技术描述
Phlebology. 2018 Sep;33(8):534-539. doi: 10.1177/0268355517734480. Epub 2017 Sep 28.
5
Endovenous 980-nm laser treatment of saphenous veins in a series of 500 patients.对500例患者的大隐静脉进行980纳米静脉内激光治疗。
J Vasc Surg. 2007 Dec;46(6):1242-7. doi: 10.1016/j.jvs.2007.08.028.
6
Endovenous laser ablation of the great and short saphenous veins with a 1320-nm neodymium:yttrium-aluminum-garnet laser: retrospective case series of 1171 procedures.1320nm 掺钕钇铝石榴石激光治疗大隐及小隐静脉曲张:1171 例回顾性病例系列研究
J Am Acad Dermatol. 2014 Feb;70(2):326-31. doi: 10.1016/j.jaad.2013.10.005. Epub 2013 Dec 4.
7
Endovenous laser ablation (980 nm) of the small saphenous vein in a series of 147 limbs with a 3-year follow-up.980nm 光纤激光腔内闭合术治疗小隐静脉 147 条肢体 3 年随访结果。
Eur J Vasc Endovasc Surg. 2010 Jan;39(1):99-103. doi: 10.1016/j.ejvs.2009.09.011. Epub 2009 Oct 15.
8
Lower energy endovenous laser ablation of the great saphenous vein with 980 nm diode laser in continuous mode.采用连续模式下的980纳米二极管激光对大隐静脉进行低能量静脉内激光消融。
Cardiovasc Intervent Radiol. 2006 Jan-Feb;29(1):64-9. doi: 10.1007/s00270-004-0317-9.
9
The 1,470-nm bare-fiber diode laser ablation of the great saphenous vein and small saphenous vein at 1-year follow-up using 8-12 W and a mean linear endovenous energy density of 72 J/cm.1470纳米裸光纤二极管激光对大隐静脉和小隐静脉进行消融,随访1年,使用8 - 12瓦功率,平均线性静脉内能量密度为72焦/厘米。
J Vasc Interv Radiol. 2014 Nov;25(11):1795-800. doi: 10.1016/j.jvir.2014.07.009. Epub 2014 Aug 22.
10
Safety and efficacy of endovenous laser ablation (EVLA) using 1940 nm and radial emitting fiber: 3-year results of a prospective, non-randomized study and comparison with 1470 nm.1940nm 及径向发射光纤行静脉内激光消融术(EVLA)的安全性和有效性:一项前瞻性、非随机研究的 3 年结果,并与 1470nm 进行比较。
Lasers Surg Med. 2022 Apr;54(4):511-522. doi: 10.1002/lsm.23500. Epub 2021 Dec 5.

引用本文的文献

1
Comparative study between endovenous laser ablation (EVLA) with 1940 nm versus EVLA with 1470 nm for treatment of incompetent great saphenous vein and short saphenous vein: A randomized controlled trial.1940纳米与1470纳米静脉内激光消融治疗大隐静脉和小隐静脉功能不全的对比研究:一项随机对照试验。
J Vasc Surg Venous Lymphat Disord. 2025 Jan;13(1):101960. doi: 10.1016/j.jvsv.2024.101960. Epub 2024 Aug 5.
2
Endovenous laser ablation (EVLA) for vein insufficiency: two-year results of a multicenter experience with 1940-nm laser diode and a novel optical fiber.静脉内激光消融术(EVLA)治疗静脉功能不全:1940nm 激光二极管和新型光纤的多中心经验两年结果。
Lasers Med Sci. 2024 Feb 15;39(1):61. doi: 10.1007/s10103-024-04000-7.
3
Laser ablation on vascular diseases: mechanisms and influencing factors.
激光消融治疗血管疾病:机制和影响因素。
Lasers Med Sci. 2023 Dec 29;39(1):18. doi: 10.1007/s10103-023-03964-2.
4
A systematic review on ablation techniques for larger saphenous veins in patients with symptomatic superficial venous disease.大隐静脉消融技术治疗有症状的浅静脉疾病患者的系统评价。
J Vasc Surg Venous Lymphat Disord. 2024 Jan;12(1):101681. doi: 10.1016/j.jvsv.2023.08.020. Epub 2023 Sep 11.
5
Safety, feasibility, and early efficacy of the water-specific 1940-nm laser wavelength for ablation of saphenous incompetence.用于治疗大隐静脉功能不全的特定水的1940纳米激光波长的安全性、可行性及早期疗效。
J Vasc Surg Cases Innov Tech. 2023 Feb 14;9(2):101125. doi: 10.1016/j.jvscit.2023.101125. eCollection 2023 Jun.
6
Endovascular laser treatment. Comparison of lasers and fibers of different generations: study of temperatures and tissue damage produced on a porcine liver model.血管内激光治疗。不同代激光和光纤的比较:在猪肝脏模型上研究产生的温度和组织损伤。
Lasers Med Sci. 2023 Apr 19;38(1):105. doi: 10.1007/s10103-023-03770-w.
7
S2k guidelines: diagnosis and treatment of varicose veins.S2k指南:静脉曲张的诊断与治疗
Hautarzt. 2022 May;73(Suppl 1):1-44. doi: 10.1007/s00105-022-04977-8. Epub 2022 Apr 19.
8
Review on Laser Technology in Intravascular Imaging and Treatment.血管内成像与治疗中的激光技术综述
Aging Dis. 2022 Feb 1;13(1):246-266. doi: 10.14336/AD.2021.0711. eCollection 2022 Feb.
9
No significant difference between 1940 and 1470 nm in endovenous laser ablation using an in vitro porcine liver model.在使用体外猪肝模型的静脉内激光消融中,1940nm 和 1470nm 之间没有显著差异。
Lasers Med Sci. 2022 Apr;37(3):1899-1906. doi: 10.1007/s10103-021-03449-0. Epub 2021 Oct 23.
10
Comparison of Short-Term Outcomes Between Endovenous 1,940-nm Laser Ablation and Radiofrequency Ablation for Incompetent Saphenous Veins.大隐静脉功能不全的1940纳米静脉腔内激光消融与射频消融短期疗效比较
Front Surg. 2020 Dec 11;7:620034. doi: 10.3389/fsurg.2020.620034. eCollection 2020.